(Q28145831)
Statements
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties (English)
0 references
October 1999
0 references
107
0 references
1
0 references
69-79
0 references